Trump signs order directing CDC to align with assessment calling for fewer childhood vaccines
President Trump has made a significant move in the realm of childhood vaccines by signing an executive order that directs the U.S. Centers for Disease Control and Prevention (CDC) to align with a scientific assessment released by the Department of Health and Human Services earlier this year. This assessment calls for fewer childhood vaccines, aligning U.S. recommendations with those of peer, developed countries.
This decision follows a memo issued by Mr. Trump in December, instructing HHS to align U.S. childhood vaccine recommendations with the best practices observed in other countries. The subsequent assessment by HHS revealed that the U.S. recommends more childhood vaccines than any peer nation, with some European countries administering half the number of vaccine doses recommended in the U.S.
In response to this assessment, the CDC updated its recommendations, reducing the number of recommended immunizations for children from 17 to 11. However, this move was met with criticism from medical experts and health organizations, including the American Academy of Pediatrics, which released its own childhood vaccine recommendations diverging significantly from the CDC guidance.
The executive order signed by President Trump on Friday directs the CDC and the CDC’s Advisory Committee on Immunization Practices to review the HHS assessment and the latest clinical data. They are tasked with updating the U.S. childhood and adolescent vaccine schedule accordingly, ensuring that Americans receive the best medical advice based on gold-standard science.
In the revised recommendations released by the CDC in January, it was determined that only children in high-risk categories should receive immunizations for certain diseases such as RSV, hepatitis, and meningococcal infections. The recommendations for 11 childhood diseases including measles, mumps, rubella, and HPV were retained, while controversial changes were made to the timing of the hepatitis B vaccine dose.
These decisions have not been without controversy, with a judge ruling against the new HHS childhood vaccine schedule recommendations in a lawsuit brought by the American Academy of Pediatrics and others. The judge found that the appointment of the new ACIP panel by Health Secretary Robert F. Kennedy Jr., a vaccine skeptic, violated federal law and disregarded the traditional scientific process for vaccine recommendations.
The Trump administration argues that American children are recommended for more vaccines compared to children in other developed countries, particularly in Europe. However, the American Academy of Pediatrics maintains that U.S. vaccine recommendations are tailored to the specific risks and healthcare system in the country, emphasizing the need for individualized approaches to vaccination.
In conclusion, the landscape of childhood vaccines in the U.S. is undergoing significant changes, with political, scientific, and medical factors all playing a role in shaping the future of immunization practices. It remains to be seen how the CDC and ACIP will navigate these challenges and ensure that children receive the most effective and safe vaccines based on sound scientific evidence.
By Kerry Breen, Jordan Freiman, and Caitlin Yilek.
